Antares Drug Patent Portfolio
Antares owns 1 orange book drug protected by 27 US patents Given below is the list of Antares's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10646495 | Testosterone ester triglyceride formulations | 30 Aug, 2038 | Active |
| US9950125 | Needle assisted jet injection administration of testosterone compositions | 04 Sep, 2036 | Active |
| US9744302 | Needle assisted jet injection device having reduced trigger force | 19 Nov, 2035 | Active |
| US11191908 | Syringe shock absorber for use in an injection device | 18 Oct, 2035 | Active |
| US12629483 | Syringe Shock Absorber For Use In An Injection Device | 07 Aug, 2035 | Active |
| US11813435 | Needle assisted injection device having reduced trigger force | 25 Feb, 2035 | Active |
| US10238662 | Needle assisted jet injection administration of testosterone compositions | 19 Feb, 2035 | Active |
| US10912782 | Needle assisted injection administration of testosterone compositions | 19 Feb, 2035 | Active |
| US11160751 | Hematocrit modulation through needle assisted jet injection of testosterone | 07 Oct, 2034 | Active |
| US11771646 | Needle assisted jet injection administration of testosterone compositions | 10 Apr, 2034 | Active |
| US10881798 | Needle assisted injection device having reduced trigger force | 11 Feb, 2034 | Active |
| US10821072 | Needle assisted jet injection administration of testosterone compositions | 04 Jun, 2033 | Active |
| US11844804 | Administration of testosterone compositions | 04 Jun, 2033 | Active |
| US10357609 | Needle assisted jet injection device having reduced trigger force | 21 Aug, 2031 | Active |
| US10905827 | Injection device with cammed ram assembly | 21 Aug, 2031 | Active |
| US11446440 | Needle assisted injection device having reduced trigger force | 21 Aug, 2031 | Active |
| US10279131 | Injection device with cammed RAM assembly | 31 Jul, 2031 | Active |
| US11497753 | Hazardous agent injection system | 19 Mar, 2030 | Active |
| US8021335 | Prefilled syringe jet injector | 04 Oct, 2026 | Expired |
| US10478560 | Prefilled syringe injector | 24 Jan, 2026 | Expired |
| US11446441 | Prefilled syringe injector | 24 Jan, 2026 | Expired |
| US8562564 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US9180259 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US9533102 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US9629959 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| USRE44846 | Needle assisted jet injector | 10 Aug, 2019 | Expired |
| USRE44847 | Needle assisted jet injector | 10 Aug, 2019 | Expired |
Latest Legal Activities on Antares's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Antares.
| Activity | Date | Patent Number |
|---|---|---|
| ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 22 Oct, 2025 | US9950125 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 06 Jun, 2025 | US11191908 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 01 May, 2025 | US11160751 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 17 Apr, 2025 | US8562564 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 26 Feb, 2025 | US9744302 |
| Correspondence Address Change | 12 Dec, 2024 | US10905827 |
| Correspondence Address Change | 12 Dec, 2024 | US10238662 |
| Correspondence Address Change | 12 Dec, 2024 | US10912782 |
| Correspondence Address Change | 12 Dec, 2024 | US11160751 |
| Correspondence Address Change | 12 Dec, 2024 | US10357609 |
| Correspondence Address Change | 12 Dec, 2024 | US11191908 |
| Correspondence Address Change | 12 Dec, 2024 | US10881798 |
| Correspondence Address Change | 12 Dec, 2024 | US10279131 |
| Correspondence Address Change | 12 Dec, 2024 | US10821072 |
| Correspondence Address Change | 12 Dec, 2024 | US11813435 |
Antares Drug Patents' Oppositions Filed in EPO
Antares drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Oct 07, 2019, by Bandpay & Greuter. This opposition was filed on patent number EP06719329A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
| |||
| EP19150366A | Sep, 2022 | Bandpay & Greuter | Granted and Under Opposition |
| EP06719329A | Oct, 2019 | Bandpay & Greuter | Patent maintained as amended |
Antares's Family Patents
Clinical Trials
Recent Clinical Trials by Antares:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
| ||||
| A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors | Antares Therapeutics, Inc | NA |
NOT YET RECRUITING
(Aug 1, 2026)
| PHASE1, PHASE2 |
Antares Drug List
Given below is the complete list of Antares's drugs and the patents protecting them.
1. Xyosted (autoinjector)
Xyosted (autoinjector) is protected by 27 patents, out of which 9 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10646495 | Testosterone ester triglyceride formulations |
30 Aug, 2038
(11 years from now)
| Active |
| US9950125 | Needle assisted jet injection administration of testosterone compositions |
04 Sep, 2036
(9 years from now)
| Active |
| US9744302 | Needle assisted jet injection device having reduced trigger force |
19 Nov, 2035
(9 years from now)
| Active |
| US11191908 | Syringe shock absorber for use in an injection device |
18 Oct, 2035
(9 years from now)
| Active |
| US12629483 | Syringe Shock Absorber For Use In An Injection Device |
07 Aug, 2035
(8 years from now)
| Active |
| US11813435 | Needle assisted injection device having reduced trigger force |
25 Feb, 2035
(8 years from now)
| Active |
| US10238662 | Needle assisted jet injection administration of testosterone compositions |
19 Feb, 2035
(8 years from now)
| Active |
| US10912782 | Needle assisted injection administration of testosterone compositions |
19 Feb, 2035
(8 years from now)
| Active |
| US11160751 | Hematocrit modulation through needle assisted jet injection of testosterone |
07 Oct, 2034
(7 years from now)
| Active |
| US11771646 | Needle assisted jet injection administration of testosterone compositions |
10 Apr, 2034
(7 years from now)
| Active |
| US10881798 | Needle assisted injection device having reduced trigger force |
11 Feb, 2034
(7 years from now)
| Active |
| US10821072 | Needle assisted jet injection administration of testosterone compositions |
04 Jun, 2033
(6 years from now)
| Active |
| US11844804 | Administration of testosterone compositions |
04 Jun, 2033
(6 years from now)
| Active |
| US10357609 | Needle assisted jet injection device having reduced trigger force |
21 Aug, 2031
(4 years from now)
| Active |
| US10905827 | Injection device with cammed ram assembly |
21 Aug, 2031
(4 years from now)
| Active |
| US11446440 | Needle assisted injection device having reduced trigger force |
21 Aug, 2031
(4 years from now)
| Active |
| US10279131 | Injection device with cammed RAM assembly |
31 Jul, 2031
(4 years from now)
| Active |
| US11497753 | Hazardous agent injection system |
19 Mar, 2030
(3 years from now)
| Active |
| US8021335 | Prefilled syringe jet injector |
04 Oct, 2026
(6 days ago)
| Expired |
| US10478560 | Prefilled syringe injector |
24 Jan, 2026
(8 months ago)
| Expired |
| US11446441 | Prefilled syringe injector |
24 Jan, 2026
(8 months ago)
| Expired |
| US8562564 | Prefilled syringe jet injector |
24 Jan, 2026
(8 months ago)
| Expired |
| US9180259 | Prefilled syringe jet injector |
24 Jan, 2026
(8 months ago)
| Expired |
| US9533102 | Prefilled syringe jet injector |
24 Jan, 2026
(8 months ago)
| Expired |
| US9629959 | Prefilled syringe jet injector |
24 Jan, 2026
(8 months ago)
| Expired |
| USRE44846 | Needle assisted jet injector |
10 Aug, 2019
(7 years ago)
| Expired |
| USRE44847 | Needle assisted jet injector |
10 Aug, 2019
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xyosted (autoinjector)'s drug page